NCT06687044

Brief Summary

During pregnancy, the physical and psychological changes of pregnant women, hyperemesis gravidarum, uterine compression, frequent urination, hip or pelvic pain, back pain, leg cramps, gastroesophageal reflux, changes in mental state, and even changes in lifestyle, habits and tastes may affect the sleep of pregnant women. Due to the coexistence of physiological, psychological, social and other complex factors during pregnancy, the incidence of sleep disorders in pregnant women is relatively high, up to 50%, and shows an increasing trend with the increase of gestational week. Not only seriously affect the quality of life of pregnant women, but also may lead to a variety of pregnancy complications, and even lead to adverse pregnancy outcomes. Therefore, early identification, timely diagnosis and treatment of sleep disorders during pregnancy are important measures to improve or even reverse adverse pregnancy outcomes. Although sleep disorders are more common and seriously harmful during pregnancy, people lack of understanding and attention to such diseases, and often regard them as normal clinical manifestations of pregnancy and neglect diagnosis and treatment. Studies have shown that maternal sleep disorders are associated with hypertensive disorders during pregnancy, preterm birth, and gestational diabetes. Current research objects mainly focus on single pregnancy, twin related research is less. The purpose of this study is to explore the perinatal sleep health of pregnant women with twin pregnancies, reduce the complications of pregnant women with twin pregnancies and improve the pregnancy outcomes of mothers and infants by improving sleep quality.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
6mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Nov 2024Nov 2026

Study Start

First participant enrolled

November 1, 2024

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

November 8, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 13, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

November 13, 2024

Status Verified

November 1, 2024

Enrollment Period

2 years

First QC Date

November 8, 2024

Last Update Submit

November 11, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Hypertension in pregnancy

    Pregnancy induced hypertension (PIH) is hypertension that occurs after 20 weeks of gestation in women with previously normal blood pressure.

    From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)

  • Gestational diabetes mellitus

    Gestational diabetes mellitus (GDM) is defined as glucose intolerance of variable degree with onset or first recognition during pregnancy

    From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)

  • Preterm labor

    Preterm labor is parturition that occurs when birth occurs between 28 weeks of gestation and 37 weeks

    From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)

  • NICU infants

    Neonatal NICU occupancy rate

    From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)

Study Arms (2)

Sleep improvement Therapy group(CBT-I)

EXPERIMENTAL
Behavioral: Sleep restrictionBehavioral: Stimulation controlBehavioral: Cognitive therapy

Control group (TAU)

PLACEBO COMPARATOR
Behavioral: Sleep principles discussion

Interventions

Go to bed before 23pm

Sleep improvement Therapy group(CBT-I)

Avoid drugs, alcohol, caffeine, and nicotine

Sleep improvement Therapy group(CBT-I)

Listen to 30 minutes of soothing music every night for 8 weeks

Sleep improvement Therapy group(CBT-I)

The principles of sleep hygiene are discussed, but without the application of stimulus control or sleep restriction

Control group (TAU)

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shengjing Hospital of China Medical University

Shenyang, Liaoning, 110004, China

Location

MeSH Terms

Conditions

Diabetes, GestationalHypertension, Pregnancy-InducedObstetric Labor, Premature

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHypertensionVascular DiseasesCardiovascular DiseasesObstetric Labor Complications

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Department of Gynecology and Obstetrics

Study Record Dates

First Submitted

November 8, 2024

First Posted

November 13, 2024

Study Start

November 1, 2024

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

November 13, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations